文献速递儿童青少年精神

孤独症风险基因Smarcc2缺陷导致认知与突触损伤及组蛋白去乙酰化酶抑制的挽救作用

Cognitive and synaptic impairment induced by deficiency of autism risk gene Smarcc2 and its rescue by histone deacetylase inhibition.
PubMed 文献 · Mol Psychiatry · 2026-08-26

本研究探讨孤独症谱系障碍(ASD)高风险基因SMARCC2单倍剂量不足导致认知与突触损伤的机制。发现ASD患者前额叶皮层SMARCC2表达降低,小鼠Smarcc2缺陷损害工作记忆并下调突触基因,电生理显示GABA能和谷氨酸能突触电流受损;Smarcc2与HDAC2结合,组蛋白乙酰化降低,romidepsin(I类HDAC抑制剂)可逆转上述异常。

要点

  • ASD患者前额叶皮层SMARCC2表达显著降低,Smarcc2缺陷小鼠工作记忆受损而社交和焦虑行为基本完好。
  • Smarcc2缺陷下调前额叶皮层突触传递相关基因,并损害锥体神经元GABA能和谷氨酸能突触电流。
  • romidepsin可恢复Smarcc2缺陷小鼠的组蛋白乙酰化、工作记忆、突触基因表达和突触电流。

核心结论

  • Smarcc2通过结合HDAC2调控组蛋白乙酰化,其缺陷导致认知和突触功能损伤,靶向HDAC可能缓解Smarcc2相关神经发育障碍的缺陷。

研究设计与样本

  • 研究采用ASD患者死后前额叶皮层、人iPSC来源神经元及Smarcc2缺陷 adolescent 小鼠模型,结合ChIP-seq、RNA-seq、qPCR和电生理记录。

主要发现

  • SMARCC2 ChIP-seq显示其结合多个参与转录调控的ASD风险基因。
  • ASD患者前额叶皮层核组分中SMARCC2表达显著降低。
  • Smarcc2缺陷小鼠前额叶皮层突触传递相关基因显著下调。
  • Smarcc2缺陷小鼠前额叶皮层锥体神经元GABA能和谷氨酸能突触电流显著受损。
  • Smarcc2缺陷导致整体组蛋白乙酰化及突触基因启动子H3K9ac富集降低。

关键数值与推荐

  • romidepsin(I类HDAC抑制剂)治疗使Smarcc2缺陷小鼠的组蛋白乙酰化、工作记忆、突触基因和突触电流正常化。

临床怎么用

  • 针对SMARCC2单倍剂量不足相关的ASD亚型,HDAC抑制可能作为改善认知和突触缺陷的潜在干预策略。

局限性

  • 原文未报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

SMARCC2, which encodes BAF170, a core subunit of chromatin remodeling BAF complex, is one of the top-ranking risk genes for autism spectrum disorder (ASD). However, the mechanisms linking SMARCC2 haploinsufficiency to ASD remain poorly understood. ChIP-seq of SMARCC2 demonstrated its binding to many other ASD risk genes involved in transcriptional regulation. SMARCC2 expression was significantly reduced in the nuclear fraction of postmortem prefrontal cortex (PFC) from patients with ASD. Smarcc2 deficiency in PFC of adolescent mice led to impaired working memory, with largely intact social and anxiety-like behaviors. Significant downregulation of genes enriched in synaptic transmission was found in PFC of Smarcc2-deficient mice by RNA-seq and qPCR profiling. Furthermore, SMARCC2 was reduced in human iPSC-derived neurons (hiPSC-N) from ASD patients, and synaptic genes were downregulated by SMARCC2 knockdown in hiPSC-N. In parallel, electrophysiological recordings uncovered the significant impairment of GABAergic and glutamatergic synaptic currents in PFC pyramidal neurons of Smarcc2-deficient mice. Smarcc2 bound to HDAC2, and Smarcc2 deficiency led to the reduced global histone acetylation and H3K9ac enrichment at synaptic gene promoters. Treatment of Smarcc2-deficient mice with romidepsin, a class I HDAC inhibitor, normalized histone acetylation, working memory, synaptic genes and currents. These findings highlight the critical role of Smarcc2 in regulating cognitive and synaptic function, suggesting that targeting HDAC could alleviate deficits in Smarcc2-associated neurodevelopmental disorders.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Li P, Men S, Patel PJ, et al. Cognitive and synaptic impairment induced by deficiency of autism risk gene Smarcc2 and its rescue by histone deacetylase inhibition. Mol Psychiatry. 2026. PMID: 42649243. doi:10.1038/s41380-026-03848-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。